Journal of Neurology

, 254:1347 | Cite as

PINK1 mutation in Taiwanese early-onset parkinsonism

Clinical, genetic, and dopamine transporter studies
  • Yi-Hsin Weng
  • Yah-Huei Wu Chou
  • Wen-Shiang Wu
  • Kun-Ju Lin
  • Hsiu-Chen Chang
  • Tzu-Chen Yen
  • Rou-Shayn Chen
  • Shiaw-Pyng Wey
  • Chin-Song Lu


The PINK1 gene mutation is probably the second most common genetic cause of early-onset Parkinson's disease (EOPD). The frequency and the characteristics of the PINK1 mutation in the Taiwanese population are unknown. This study was designed to investigate the genotype, phenotype and dopaminergic function of PINK1 in a cohort of EOPD patients. The genetic settings were to detect the PINK1 gene mutations in 138 EOPD patients and in 191 controls. Using the 99mTc-TRODAT-1 (TRODAT) scan, we investigated the differences in the dopamine transporter (DAT) activities between the PINK1 patients, late-onset Parkinson's disease (LOPD) patients and healthy controls. Four EOPD patients with 3 genotypic mutations in the PINK1 gene were found: a compound heterozygous mutation (Q239X/R492X) in 2 sisters, a novel homozygous mutation (R492X) in a woman, and a novel heterozygous mutation (G193R) in a man. The three PINK1 patients had typical phenotype with juvenile onset, benign course, and frequently with dyskinesias. The TRODAT scan showed a rather even and symmetrical reduction of uptake in PINK1 patients, unlike the dominant decline in the putamen in the LOPD patients. The annual reduction rate of uptake in the striatum was much slower in PINK1 patients than that in the LOPD patients (1.7 % vs. 4.1%; p<0.005). In the patient with a heterozygous mutation in the PINK1 gene, the reduction ratio in the striatum, as well as the annual reduction rate, were closer to those in the LOPD group. We conclude that the incidence of carrying PINK1 mutations in the present cohort of Taiwanese EOPD patients was low, accounting for 2/39 (5.1 %) in familial cases, and 2/99 (2 %) in sporadic cases. The slower annual reduction of DAT activity might indicate the insidious degeneration of dopamine neurons and a benign prognosis.

Key words

PINK1 gene early-onset Parkinson's disease dopamine transporter 99mTc-TRODAT-1 SPECT 


  1. 1.
    Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson Disease in Twins: An Etiologic Study. JAMA 281:341-46CrossRefPubMedGoogle Scholar
  2. 2.
    Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G, Heutink P (2003) DJ-1(PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24:159-60CrossRefPubMedGoogle Scholar
  3. 3.
    Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-Synuclein Gene Identified in Families with Parkinson's Disease. Science 276:2045-047CrossRefPubMedGoogle Scholar
  4. 4.
    Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44:595-00Google Scholar
  5. 5.
    Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-08CrossRefPubMedGoogle Scholar
  6. 6.
    Rogaeva E, Johnson J, Lang AE, Gulick C, Gwinn-Hardy K, Kawarai T, Sato C, Morgan A, Werner J, Nussbaum R, Petit A, Okun MS, McInerney A, Mandel R, Groen JL, Fernandez HH, Postuma R, Foote KD, Salehi-Rad S, Liang Y, Reimsnider S, Tandon A, Hardy J, George-Hyslop P, Singleton AB (2004) Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 61:1898-904CrossRefPubMedGoogle Scholar
  7. 7.
    Valente EM, Brancati F, Caputo V, Graham EA, Davis MB, Ferraris A, Breteler MM, Gasser T, Bonifati V, Bentivoglio AR, De Michele G, Durr A, Cortelli P, Filla A, Meco G, Oostra BA, Brice A, Albanese A, Dallapiccola B, Wood NW, European Consortium on Genetic Susceptibility in Parkinson's Disease (2002) PARK6 is a common cause of familial parkinsonism. Neurol Sci 23:S117-18CrossRefPubMedGoogle Scholar
  8. 8.
    Valente EM, Brancati F, Ferraris A, Graham EA, Davis MB, Breteler MM, Gasser T, Bonifati V, Bentivoglio AR, De Michele G, Durr A, Cortelli P, Wassilowsky D, Harhangi BS, Rawal N, Caputo V, Filla A, Meco G, Oostra BA, Brice A, Albanese A, Dallapiccola B, Wood NW, European Consortium on Genetic Susceptibility in Parkinson's Disease (2002) PARK6-linked parkinsonism occurs in several European families. Ann Neurol 51:14-8CrossRefPubMedGoogle Scholar
  9. 9.
    Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 56:336-41CrossRefPubMedGoogle Scholar
  10. 10.
    Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary earlyonset Parkinson's disease caused by mutations in PINK1. Science 304:1158-160CrossRefPubMedGoogle Scholar
  11. 11.
    Ibanez P, Lesage S, Lohmann E, Thobois S, De MG, Borg M, Agid Y, Durr A, Brice A, French Parkinson's Disease Genetics Study Group (2006) Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain 129:686-94CrossRefPubMedGoogle Scholar
  12. 12.
    Hatano Y, Li Y, Sato K, Asakawa S, Yamamura Y, Tomiyama H, Yoshino H, Asahina M, Kobayashi S, Hassin-Baer S, Lu CS, Ng AR, Rosales RL, Shimizu N, Toda T, Mizuno Y, Hattori N (2004) Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol 56:424-27CrossRefPubMedGoogle Scholar
  13. 13.
    Healy DG, Abou-Sleiman PM, Ahmadi KR, Muqit MM, Bhatia KP,Quinn NP, Lees AJ, Latchmann DS, Goldstein DB, Wood NW (2004) The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism. Ann Neurol 56:329-35CrossRefPubMedGoogle Scholar
  14. 14.
    Healy DGM, Abou-Sleiman PMP, Gibson JMM, Ross OAP, Jain SB, Gandhi SM, Gosal DM, Muqit MMK, Wood NWP, Lynch TM (2004) PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology 63:1486-488PubMedGoogle Scholar
  15. 15.
    Albanese A, Valente EM, Romito LM, Bellacchio E, Elia AE, Dallapiccola B (2005) The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology 64:1958-960CrossRefPubMedGoogle Scholar
  16. 16.
    Bentivoglio AR, Cortelli P, Valente EM, Ialongo T, Ferraris A, Elia A, Montagna P, Albanese A (2001) Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord 16:999-006CrossRefPubMedGoogle Scholar
  17. 17.
    Lohmann E, Periquet M, Bonifati V, Wood NW, De Michele G, Bonnet AM, Fraix V, Broussolle E, Horstink MW, Vidailhet M, Verpillat P, Gasser T, Nicholl D, Teive H, Raskin S, Rascol O, Destee A, Ruberg M, Gasparini F, Meco G, Agid Y, Durr A, Brice A (2003) How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 54:176-85CrossRefPubMedGoogle Scholar
  18. 18.
    Saito M, Maruyama M, Ikeuchi K, Kondo H, Ishikawa A, Yuasa T, Tsuji S (2000) Autosomal recessive juvenile parkinsonism. Brain Develop 22:115-17CrossRefGoogle Scholar
  19. 19.
    Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ, Piccini P (2002) Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 52:849-53CrossRefPubMedGoogle Scholar
  20. 20.
    Kessler KR, Hamscho N, Morales B, Menzel C, Barrero F, Vives F, Gispert S, Auburger G (2005) Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinsons syndrome. J neural transm 112:1345-353CrossRefPubMedGoogle Scholar
  21. 21.
    Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC (2004) 99mTc-TRODAT-1 imaging of multiple system atrophy. J Nucl Med 45:49-5PubMedGoogle Scholar
  22. 22.
    Lu CS, Chang HC, Kuo PC, Liu YL, Wu WS, Weng YH, Yen TC, Chou YH (2004) The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. Parkinsonism Related Disord 10:369-73CrossRefGoogle Scholar
  23. 23.
    Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH (2004) The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 61:35-8CrossRefPubMedGoogle Scholar
  24. 24.
    Yen TC, Lu CS, Tzen KY, Wey SP, Chou YH, Weng YH, Kao PF, Ting G (2000) Decreased dopamine transporter binding in Machado-Joseph disease. J Nucl Med 41:994-98PubMedGoogle Scholar
  25. 25.
    Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS (2004) Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. J Nucl Med 45:393-01PubMedGoogle Scholar
  26. 26.
    Hatano Y, Sato K, Elibol B, Yoshino H, Yamamura Y, Tomiyama H, Bonifati V, Shinotoh H, Asahina M, Kobayashi S, Ng AR, Rosales RL, Hassin-Baer S, Shinar Y, Lu CS, Chang HC, Wu-Chou YH, Atac FB, Kobayashi T, Toda T, Mizuno Y, Hattori N (2004) PARK6-linked autosomal recessive early-onset parkinsonism in Asia populations. Neurology 63:1482-485PubMedGoogle Scholar
  27. 27.
    Li Y, Tomiyama H, Sato K, Hatano Y, Yoshino H, Atsumi M, Kitaguchi M, Sasaki S, Kawaguchi S, Miyajima H, Toda T, Mizuno Y, Hattori N (2006) Clinicogenetic study of PINK1 mutations in autosomal recessive earlyonset parkinsonism. Neurology 64:1955-957CrossRefGoogle Scholar
  28. 28.
    Lu CS, Wu Chou YH, Weng YH, Chen RS (2006) Genetic and DAT imaging studies of familial parkinsonism in a Taiwanese cohort. J Neural Transm 70(Suppl):235-40CrossRefGoogle Scholar
  29. 29.
    Chung EJ, Ki CS, Lee WY, Kim IS, Kim JY (2006) Clinical features and gene analysis in Korea patients with early-onset Parkinson disease. Arch Neurol 63:1170-174CrossRefPubMedGoogle Scholar
  30. 30.
    Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O, Schwinger E, Vieregge P, Lang AE, Breakefield XO, Ozelius LJ, Pramstaller PP, Klein C (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649-656CrossRefPubMedGoogle Scholar
  31. 31.
    Khan NL, Brook DJ, Pavese, N, Sweeney MG, Wood NW, Lees AJ, Piccini P (2002) Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain 125:2248-256CrossRefPubMedGoogle Scholar
  32. 32.
    Mozley PD, Acton PD, Barraclough ED, Plossl K, Gur RC, Alavi A, Mathur A, Saffer J, Kung HF (1999) Effects of age on dopamine transporters in healthy humans. J Nucl Med 40:1812-817PubMedGoogle Scholar
  33. 33.
    Gandhi S, Muqit MMK, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, Latchman DS, Holton JL, Wood NW, Revesz T (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129:1720-731CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • Yi-Hsin Weng
    • 1
    • 5
  • Yah-Huei Wu Chou
    • 2
    • 5
  • Wen-Shiang Wu
    • 1
  • Kun-Ju Lin
    • 3
    • 5
  • Hsiu-Chen Chang
    • 1
  • Tzu-Chen Yen
    • 3
    • 5
  • Rou-Shayn Chen
    • 1
    • 5
  • Shiaw-Pyng Wey
    • 4
  • Chin-Song Lu
    • 1
    • 5
  1. 1.Neuroscience Research Center, Section of Movement Disorders, Dept. of NeurologyChang Gung Memorial Hospital and Chang Gung UniversityKweishan, TaoyuanTaiwan
  2. 2.Human Molecular Genetic LaboratoryChang Gung Memorial Hospital Chang Gung University College of MedicineKweishan, TaoyuanTaiwan
  3. 3.Dept. of Nuclear MedicineChang Gung Memorial Hospital Chang Gung University College of MedicineKweishan, TaoyuanTaiwan
  4. 4.Dept. of Medical Imaging and Radiological SciencesChang Gung Memorial Hospital Chang Gung University College of MedicineKweishan, TaoyuanTaiwan
  5. 5.Neuroscience Research CenterChang Gung Memorial Hospital, Chang Gung University College of MedicineChang Gung

Personalised recommendations